Vasculitis & polymyalgia rheumatica
Validation of the Behçet’s Syndrome Overall Damage Index (BODI) for retrospective studies and a proposal for modification
Performance · Correlation between retrospective and face-to-face BODIResult — go to the resultICC 0.99 95% CI 0.99–0.99Authors' conclusion
BODI seems to be a reliable and feasible instrument for assessing damage in retrospective studies.
Study context
- Population
- Behçet's syndrome patients with at least two clinic visits at 1-year intervals
- Participants
- 300 patients
- Comparison
- BODI scored from retrospective patient charts vs face-to-face visits
- Outcome
- Construct validity of BODI for retrospective studies: agreement between retrospective chart and face-to-face BODI scores
Methodological detailsretrospective chart data, blinded scoring
- Retrospective chart data
- Blinded scoring
Performance
As reported in the abstract
Correlation between retrospective and face-to-face BODI
ICC
0.99
95% CI 0.99–0.99
Further findings
Inter-observer and intra-observer agreement (retrospective chart data)
- Inter-observer agreement, ICC
- 0.96
- Intra-observer agreement (6 months apart), ICC
- 1
- Good agreement
Main damage items not captured by BODI
- Hypertension, liver failure, lung parenchymal involvement, glaucoma and lymphedema
Original publication
Validation of the Behçet’s Syndrome Overall Damage Index (BODI) for retrospective studies and a proposal for modification. Rheumatology (Oxford). Published 11 May 2024. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →